GrantNIH REPORTERMay 11
New NIH Grant: Fragment-based drug discovery against oncogenic microRNA precursors using high-throughput crystallog — $528K at Unknown Institution
Scientists are getting $528,000 to develop new cancer-fighting drugs that target microRNA precursors—tiny pieces of genetic material that help cancer cells grow. They're using a technique called fragment-based drug discovery and high-throughput crystallography to design small molecules that can block the production of cancer-causing microRNAs. This research could open up entirely new ways to treat various cancers by targeting structures in cells that were previously thought impossible to drug.
WHY IT MATTERSThis research could eventually lead to new treatment options for patients with cancers driven by oncogenic microRNAs, potentially offering alternatives when standard therapies fail or aren't suitable.
ℹ Good to know